Data / Form D filings / CeleCor Therapeutics, Inc.
CeleCor Therapeutics, Inc.: Form D filings
CeleCor Therapeutics, Inc., a pharmaceuticals company in Del Mar, CA, filed 6 Form D notices with the SEC between 2017 and 2026. The latest, on July 9, 2026, reports $11.9 million sold of a $15 million offering to 17 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1155 CAMINO DEL MAR SUITE 481, Del Mar, CA, 92014
- Phone
- (858) 777-9750
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1705381
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | New notice | $15,000,000 | $11,856,325 | $3,143,675 | 17 | Jun 9, 2026 | sec.gov |
| Aug 21, 2024 | Amendment | $45,500,000 | $45,500,000 | 11 | Feb 23, 2022 | sec.gov | |
| Aug 3, 2023 | Amendment | $42,500,000 | $17,750,000 | $24,750,000 | 11 | Feb 23, 2022 | sec.gov |
| Mar 8, 2022 | New notice | $7,500,000 | $2,700,000 | $4,800,000 | 4 | Feb 23, 2022 | sec.gov |
| May 10, 2021 | New notice | $5,000,000 | $1,000,000 | $4,000,000 | 1 | May 3, 2021 | sec.gov |
| May 3, 2017 | New notice | $25,000,000 | $0 | $25,000,000 | 5 | Apr 27, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert S. Hillman, Ph.D. | Executive Officer, Director | |
| Andreas Ritzi | Director | |
| Jack Lief | Director | |
| Peter B. Finn | Executive Officer | Secretary |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jul 6, 2026 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what CeleCor Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.